Skip to content

External Oblique Intercostal Block With or Without Intravenous Lidocaine Infusion for Analgesia in Patients Undergoing Gastric Bypass Surgery

External Oblique Intercostal Block With or Without Intravenous Lidocaine Infusion for Analgesia in Patients Undergoing Gastric Bypass Surgery: a Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07809425
Enrollment
100
Registered
2026-09-09
Start date
2026-09-15
Completion date
2027-02-01
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese Patients

Brief summary

Adding a perioperative lidocaine infusion (1.5 mg/kg loading + 1.5 mg/kg/h) to bilateral EOIB and low dose fentanyl loading reduces intraoperative fentanyl consumption (ANI guided rescue) compared to placebo, without increasing adverse events.

Interventions

DRUGInvestigatore hypothesize that adding a perioperative lidocaine infusion (1.5 mg/kg loading + 1.5 mg/kg/h) to bilateral EOIB and low dose fentanyl loading reduces intraoperative fentanyl consumption.

Adding a perioperative lidocaine infusion (1.5 mg/kg loading + 1.5 mg/kg/h) to bilateral EOIB and low dose fentanyl loading reduces intraoperative fentanyl consumption (ANI guided rescue) compared to placebo, without increasing adverse events.

OTHERBilateral EOIB + fentanyl 1 μg/kg loading + normal saline loading (equivalent volume) + normal saline infusion (equivalent rate).

Bilateral EOIB + fentanyl 1 μg/kg loading + normal saline loading (equivalent volume) + normal saline infusion (equivalent rate).

Sponsors

Menoufia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-60 years. * BMI ≥ 35 kg/m². * ASA physical status II or III. * Scheduled for elective laparoscopic Roux en Y gastric bypass. * Ability to provide written informed consent.

Exclusion criteria

* Refusal. * Allergy or contraindication to lidocaine, fentanyl, ropivacaine, or any study medication. * Chronic opioid use or dependence. * Significant hepatic (AST/ALT\> 3× normal, cirrhosis) or renal impairment (CrCl\< 30 mL/min). * Second or third degree AV block or significant bradyarrhythmia without pacemaker. * Coagulopathy, anticoagulation incompatible with regional anesthesia, or infection at block site. * Pregnancy or lactation. * Severe psychiatric or cognitive disorder. * Failed bilateral EOIB (absence of sensory loss in T6-T10 after 30 min) - excluded from analysis.

Design outcomes

Primary

MeasureTime frameDescription
Total intraoperative fentanyl consumptionIntraoperative time, during surgeryTotal intraoperative fentanyl consumption (μg) = loading dose (1 μg/kg) + rescue boluses.

Secondary

MeasureTime frameDescription
Postoperative morphine consumptionThe first 24 hoursPostoperative morphine consumption (mg) at 24 hours.
First rescue fentanyl and time to first postoperative morphineThe first 24 hoursTime to first rescue fentanyl (from induction to first bolus) and Time to first postoperative morphine (from PACU arrival to first dose).
Pain scoresUpon arrival, 1 hour, 2 hours, 6 hours, 12 hours, 24 hours.Pain scores (VAS score ranging 0-100) at Post Anesthetic Care Unit arrival, 1 hour, 2 hours, 6 hours, 12 hours, 24 hours.

Countries

Egypt

Contacts

CONTACTNevine Mostafa Soliman
mostafanevine@gmail.com+201128861471

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026